Invus Financial Advisors, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 7Value: $89.2MLatest: 2024Q2

Invus Financial Advisors, LLC is an institutional investment manager that filed its latest Form 13F for 2024Q2, reporting 7 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ORIC",
  "NVCR",
  "RCUS",
  "IONQ",
  "TBLA",
  "IHS",
  "CPNG"
]

Filing Details

13F-HR • 2024-06-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-06-30
Filing Date: 2024-08-14
Total Holdings: 7
Total Value: 89240348
Accession Number: 0001214659-24-014750
Form Type: 13F-HR
CIK: invus-financial-advisors
Manager Name: Invus-Financial-Advisors

Data Enrichment

100% identified

7 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

7 positions • $89.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Taboola.com Ltd.

TBLA|M8744T106

Shares:10.0M

Value:$34.3M

% of Portfolio:38.4% ($34.3M/$89.2M)

Arcus Biosciences, Inc.

RCUS|03969F109

Shares:1.6M

Value:$24.6M

% of Portfolio:27.5% ($24.6M/$89.2M)

IHS Holding Ltd

IHS|G4701H109

Shares:2.4M

Value:$7.5M

% of Portfolio:8.5% ($7.5M/$89.2M)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:1.0M

Value:$7.1M

% of Portfolio:8.0% ($7.1M/$89.2M)

Coupang, Inc.

CPNG|22266T109

Shares:295.9K

Value:$6.2M

% of Portfolio:6.9% ($6.2M/$89.2M)

NovoCure Ltd

NVCR|G6674U108

Shares:350.9K

Value:$6.0M

% of Portfolio:6.7% ($6.0M/$89.2M)

IonQ, Inc.

IONQ|46222L108

Shares:500.0K

Value:$3.5M

% of Portfolio:3.9% ($3.5M/$89.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Taboola.com Ltd.(TBLAcusipM8744T106)	10.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$34.3M	38.4% ($34.3M/$89.2M)	QoQ -22.52% (-$10.0M) YoY-
Arcus Biosciences, Inc.(RCUScusip03969F109)	1.6M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$24.6M	27.5% ($24.6M/$89.2M)	QoQ -19.33% (-$5.9M) YoY-
IHS Holding Ltd(IHScusipG4701H109)	2.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$7.5M	8.5% ($7.5M/$89.2M)	QoQ -9.34% (-$778.0K) YoY-
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	1.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$7.1M	8.0% ($7.1M/$89.2M)	QoQ -48.58% (-$6.7M) YoY-
Coupang, Inc.(CPNGcusip22266T109)	295.9K	QoQ -71.43% (-740.0K) YoY-	All Managers (Combined)	$6.2M	6.9% ($6.2M/$89.2M)	QoQ -66.35% (-$12.2M) YoY-
NovoCure Ltd(NVCRcusipG6674U108)	350.9K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$6.0M	6.7% ($6.0M/$89.2M)	QoQ +9.59% (+$526.3K) YoY-
IonQ, Inc.(IONQcusip46222L108)	500.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$3.5M	3.9% ($3.5M/$89.2M)	QoQ -29.62% (-$1.5M) YoY-